Kodiak Sciences (KOD) announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with ...

Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with diabetic retinopathy ("DR").

Usha (name changed), 62, was experiencing sudden and painless loss of vision in the right eye for one day when she turned up ...

Diabetes can affect many parts of the body, including the eyes. Routine eye exams can help identify the early stages of eye ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bwcc18604 ...

The machine at Centre for Sight has a technology called ‘Foresight’ which is a form of predictive AI, designed to address irregularities in the cornea ...

Bacterial vaginosis affects nearly a third of women worldwide and can cause infertility, premature births and newborn deaths.

A new study published in the journal of Nature Microsystems & Nanoengineering found that spore-forming microbial whole-cell sensing strategy to be a promising strategy in the management ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

A common bacterial infection of the vagina is actually a sexually transmitted disease that can be helped by also treating male sexual partners, researchers have discovered.